An Expert Panel on Severe Asthma: From the Epithelium to Better Patient Outcomes

Severe asthma has been clearly tied to significant medical, psychological, social, and economic risks and burdens for affected patients and their families. Despite the clear need for comprehensive and intensive management, substantial gaps in patient care persist. This live Expert Roundtable"with 3 internationally recognized asthma experts who have extensive experience in clinical research, patient care, and clinician education"will cover key clinical issues involving the use of biologics in severe asthma. Topics will include, but not be limited to, patient selection and timely initiation of biologics; underlying mechanisms of disease and characteristic phenotypes that can help guide biologic selection; and recommendations for managing common challenges, such as achieving asthma control, OCS weaning, treatment failure, biologic switching, and mitigating treatment side effects.